We are live on
!
Find out more
PP
PDS Planning Portfolio holdings
AUM
$1.52B
1-Year Est. Return
18.08%
This Fund
S&P 500
This Quarter
Est. Return
+5.11%
1 Year Est. Return
+18.08%
3 Year Est. Return
+48.56%
5 Year Est. Return
+51.38%
10 Year Est. Return
–
AUM
$725M
AUM Growth
+$99.6M
(+16%)
Cap. Flow
+$73.2M
Cap. Flow
% of AUM
10.1%
Top 10 Holdings %
Top 10 Hldgs %
49.96%
Holding
309
New
83
Increased
189
Reduced
26
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.49M |
| 2 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$3.17M |
| 3 |
Apple
AAPL
|
+$2.9M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$2.51M |
| 5 |
Microsoft
MSFT
|
+$2.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core 1-5 Year USD Bond ETF
ISTB
|
+$410K |
| 2 |
iShares Core International Aggregate Bond Fund
IAGG
|
+$304K |
| 3 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$300K |
| 4 |
iShares Core 60/40 Balanced Allocation ETF
AOR
|
+$268K |
| 5 |
State Street Global Allocation ETF
GAL
|
+$267K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.67% |
| 2 | Healthcare | 7.3% |
| 3 | Financials | 3.7% |
| 4 | Industrials | 2.43% |
| 5 | Consumer Staples | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Lumen
LUMN
$6.57B
| $30.5K | ﹤0.01% |
+11,505
| New | +$46.4K |
|
302
Lufax Holding
LU
$1.35B
| $27.2K | ﹤0.01% |
+3,334
| New | +$32K |
|
|
CS
303
DELISTED
Credit Suisse Group
CS
| $11.3K | ﹤0.01% |
+12,711
| New | +$35.5K |
|
|
APTO
304
DELISTED
Aptose Biosciences, Inc.
APTO
| $6.4K | ﹤0.01% |
22
| – | – |
|
|
BINI
305
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | – |
|
|
306
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.5B
| – | – |
-6,320
| Closed | -$300K |
|
307
PNC Financial Services
PNC
$99.7B
| – | – |
-1,381
| Closed | -$218K |
|
308
Invesco Dorsey Wright Basic Materials Momentum ETF
PYZ
$72.2M
| – | – |
-1,931
| Closed | -$153K |
|
|
NAVB
309
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| – | – |
-10,565
| Closed | -$2.22K |
|
Similar funds
AM
FCM
ARAM
KP
MCIL
KCM
ACL
RG
PDS Planning's Q1 2023 Portfolio in Review
As of Q1 2023, PDS Planning held 309 positions worth $725M, up 16% from $626M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
PDS Planning deployed $73.2M of net new capital in Q1 2023, opening 83 new positions and adding to 189 existing holdings. Its largest new stake was Morgan Stanley: 5,078 shares worth $446K.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, up from 5.3% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core 1-5 Year USD Bond ETF, an estimated $410K trimmed.
- PDS Planning's largest Q1 2023 buy was Morgan Stanley: 5,078 shares worth $446K.
- PDS Planning added most to iShares Core US Aggregate Bond ETF in Q1 2023, an estimated $3.49M increase.
- PDS Planning's biggest Q1 2023 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $410K.
- PDS Planning fully exited iShares MSCI Emerging Markets ex China ETF in Q1 2023, selling an estimated $300K.
- PDS Planning's ten largest holdings make up 50% of its $725M portfolio in Q1 2023.
- PDS Planning opened 83 new positions and closed 4 in Q1 2023.
- PDS Planning's portfolio value rose 16% quarter-over-quarter to $725M.
Based on PDS Planning's 13F filing for Q1 2023, filed 2 May 2023.